REDWOOD CITY, Calif.,
March 2, 2018 /PRNewswire/
-- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty
pharmaceutical company, today announced that it will release fourth
quarter and yearly financial results after market close on
Thursday, March 8th, 2018. AcelRx
management will host an investment-community conference call at
4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on March 8th, 2018 to discuss the financial results
and provide a corporate update.
Investors who wish to participate in the conference call may do
so by dialing (866) 361-2335 for domestic callers, (855) 669-9657
for Canadian callers or (412) 902-4204 for international callers.
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investors page of the company's
website at www.acelrx.com and clicking on the webcast link on the
Investors home page.
A webcast replay will be available on the AcelRx website for 90
days following the call by visiting the Investor page of the
company's website at www.acelrx.com.
About AcelRx Pharmaceuticals, Inc.
AcelRx
Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of innovative therapies
for the treatment of moderate-to-severe acute pain. AcelRx's
proprietary, non-invasive sublingual formulation technology
delivers sufentanil with consistent pharmacokinetic profiles. The
company has two product candidates including DSUVIA™ (sufentanil
sublingual tablet, 30 mcg), known as DZUVEO outside the United States, with a proposed indication
for the treatment of moderate-to-severe acute pain in medically
supervised settings, and ZALVISO® (sufentanil sublingual tablet
system, SST system, 15 microgram) being developed as an
innovatively designed patient-controlled analgesia (PCA) system for
reduction of moderate-to-severe acute pain in medically supervised
settings.
For additional information about AcelRx's clinical programs,
please visit www.acelrx.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-to-hold-annual-2017-financial-results-conference-call-and-webcast-on-thursday-march-8th-2018-300607287.html
SOURCE AcelRx Pharmaceuticals, Inc.